| 生物活性 | |||
|---|---|---|---|
| 描述 | MK-0608 is a potent oral inhibitor of HCV replication in vitro with an EC50 of 0.3 μM in a subgenomic replicon assay [1]. | ||
| 实验方案 | |||
|---|---|---|---|
| 1mg | 5mg | 10mg | |
|
1 mM 5 mM 10 mM |
3.57mL 0.71mL 0.36mL |
17.84mL 3.57mL 1.78mL |
35.68mL 7.14mL 3.57mL |
| 参考文献 |
|---|